We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Codrin Lungu

Codrin I. Lungu MD

Program Director, Division of Clinical Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland

Dr. Codrin Lungu is a board-certified neurologist specializing in movement disorders, with expertise in multiple aspects of clinical neurology.

Previously, Dr. Lungu had been the Chief of the NIH Parkinson clinic, which he led for over 5 years. He also established, in collaboration with the Surgical Neurology Branch, the first NIH Deep Brain Stimulation program, and has led the NIH Botulinum Toxin clinic for 8 years. His experience includes research in imaging biomarkers, neuromodulation, and early clinical trials of novel therapeutic agents.

In the current role, Dr. Lungu provides guidance and leadership for the development and implementation of clinical research, develops initiatives aimed and reducing neurological disease burden, and promotes and coordinates collaborative research in neurology and related fields. He serves as Project Officer and Project Scientist on studies in various stages, including large trial networks.

He also continues to be involved in clinical research and teaching activities in the NIH Clinical Center and the NIH Movement Disorders Fellowship Program.